Literature DB >> 16357627

Diagnosis and treatment of VIPoma in a female patient.

Carol Ann Remme1, Gerrit H de Groot, Gideon Schrijver.   

Abstract

We report a case of VIPoma in an 83-year-old female patient, who presented with frequent and excessive diarrhoea, muscle weakness, and severe hypokalaemia. Abdominal computed tomography (CT) revealed a 4x6 cm mass in the body of the pancreas. Laboratory analysis showed elevated levels of both vasoactive intestinal polypeptide (VIP; 153 pmol/l) and pancreatic polypeptide (161 pmol/l). In view of the patient's age, physical condition, and tumour size, surgical resection was not performed. The patient was treated with a long-acting octreotide, after which her symptoms diminished. After 24 months of follow-up, the patient remained in good physical condition without any further serious gastrointestinal symptoms. The VIPoma syndrome is caused by a neuroendocrine tumour, usually located in the pancreas, which secretes VIP, causing severe diarrhoea, dehydration and hypokalaemia. Treatment options include resection of the tumour, chemotherapy or the reduction of symptoms with somatostatin analogues. We provide an overview of the incidence, pathophysiology, diagnosis, treatment strategies, and prognosis of this rare syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16357627     DOI: 10.1097/00042737-200601000-00017

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  3 in total

1.  Multiple-phase spiral CT findings of pancreatic vasoactive intestinal peptide-secreting tumor: A case report.

Authors:  Ying Chen; Dan Shi; Fei Dong; Shu-Gao Han; Zi-Hua Qian; L I Yang; Ying Wang; Ri-Sheng Yu; Qing-Hai Li; Yan-Biao Fu
Journal:  Oncol Lett       Date:  2015-08-17       Impact factor: 2.967

Review 2.  Vasoactive intestinal peptide secreting tumour: An overview.

Authors:  Esther Una Cidon
Journal:  World J Gastrointest Oncol       Date:  2022-04-15

3.  Laparoscopic resection of VIPoma presenting at an unusual location.

Authors:  Ravi Kiran Thota; Srikanth Gadiyaram
Journal:  J Minim Access Surg       Date:  2022 Jul-Sep       Impact factor: 1.018

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.